Forgot your password?
It is hoped that the approval will support treatment continuity for patients
The decision gives patients access to a therapy that targets the interleukin-36 pathway for the first time
Psoriatic arthritis affects around 30% of psoriasis patients
The trial has been evaluating the drug in patients with darker skin tones
The long-term study has been evaluating the drug in over 1,900 patients with moderate-to-severe cases
The partners will aim to advance cutaneous drug delivery for the rare genetic skin disorders
The drug is approved for plaque psoriasis, hidradenitis suppurativa and other inflammatory conditions
Up to 90% of patients primary biliary cholangitis experience pruritus
The gene therapy demonstrated significant wound healing and pain reduction in RDEB
Over 300,000 chronic spontaneous urticaria patients in the US are inadequately controlled by antihistamines